Chang Gung medical journal · 2003
A retrospective immunohistochemical and clinicopathological study of small cell carcinomas of the urinary tract.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chuang Cheng-Keng, Liao Shuen-Kuei
Аннотация
BACKGROUND: To investigate the immunohistochemical and clinicopathological behaviors of primary urinary tract small cell carcinomas (SCCs).
METHODS: A retrospective study of 10 cases of urinary tract SCC (7 men and 3 women, average age, 54; range, 35-78 years) at Chang Gung Memorial Hospital is reported. Among these cases, 3 tumors arose from the kidney, 2 from the renal pelvis, 2 from the ureter, and 3 from the bladder. Clinical and follow-up data were obtained. Histological and immunohistochemical studies with antibodies to neuroendocrine (NE) markers were conducted.
RESULTS: The most prominent common feature of the 10 SCCs was their cell histopathology: small to medium-sized round to spindle-shaped cells with scanty cytoplasm, hyperchromatic nuclei, and inconspicuous nucleoli. Immunostaining revealed positive neuron-specific enolase (NSE) reactivity in 10 of 10 tumors, but there was focal and weak staining for chromogranin-A (CgA) in 4 of 10 tumors. The 7 patients with vimentin-positive SCCs all developed metastatic lesions, and 5 of them expired within 1 year.
CONCLUSIONS: SCCs of the urinary tract system share similar histopathological features and NE markers with their pulmonary counterpart. NSE was expressed more consistently than CgA in these tumors. However, the preferential expression of NSE and intensity of immunostaining of these 2 NE markers did not predict the clinical outcome of these patients. The presence of both SCC and transitional cell carcinoma or SCC alone did not foretell the clinical outcome either. Patients with the presence of vimentin in the tumor tissues appeared to have poorer prognoses with early metastasis and mortality.
METHODS: A retrospective study of 10 cases of urinary tract SCC (7 men and 3 women, average age, 54; range, 35-78 years) at Chang Gung Memorial Hospital is reported. Among these cases, 3 tumors arose from the kidney, 2 from the renal pelvis, 2 from the ureter, and 3 from the bladder. Clinical and follow-up data were obtained. Histological and immunohistochemical studies with antibodies to neuroendocrine (NE) markers were conducted.
RESULTS: The most prominent common feature of the 10 SCCs was their cell histopathology: small to medium-sized round to spindle-shaped cells with scanty cytoplasm, hyperchromatic nuclei, and inconspicuous nucleoli. Immunostaining revealed positive neuron-specific enolase (NSE) reactivity in 10 of 10 tumors, but there was focal and weak staining for chromogranin-A (CgA) in 4 of 10 tumors. The 7 patients with vimentin-positive SCCs all developed metastatic lesions, and 5 of them expired within 1 year.
CONCLUSIONS: SCCs of the urinary tract system share similar histopathological features and NE markers with their pulmonary counterpart. NSE was expressed more consistently than CgA in these tumors. However, the preferential expression of NSE and intensity of immunostaining of these 2 NE markers did not predict the clinical outcome of these patients. The presence of both SCC and transitional cell carcinoma or SCC alone did not foretell the clinical outcome either. Patients with the presence of vimentin in the tumor tissues appeared to have poorer prognoses with early metastasis and mortality.